Regulatory

Articles

Bioventus Gains FDA Clearance of SIGNAFUSE Bone Graft Strip

Bioventus Gains FDA Clearance of SIGNAFUSE Bone Graft Strip
Bioventus received FDA 510(k) clearance to market SIGNAFUSE® Bioactive Bone Graft in a strip format. The strips consist of 55% bioglass by weight and have been shown to induce higher levels of osteoblast differentiation compared to other synthetic bone graft strips....